The U.S. Food and Drug Administration (FDA) has granted traditional full approval to the CAR-T cell therapy Tecartus ...
FDA NDA for bezuclastinib targets post-imatinib GIST, leveraging Real-Time Oncology Review and prior breakthrough therapy ...
In lymphedema, dermatitis and excoriation can precipitate inflammatory swelling and increase cellulitis risk, making barrier ...
A study led by researchers at a community hospital in Sapporo, Japan found that comprehensive genomic testing using a ...
Christine Fader shares how her husband’s past trauma shaped his cancer treatment experience and why awareness and patient ...
New ELCC 2026 data show longer survival, better brain metastases control and more personalized treatment options for patients ...
A couple opens up about navigating cancer care, advocating for themselves and balancing caregiver responsibilities with ...
In this segment, Dr. Gregory Vidal outlines what a typical first-line treatment plan looks like for patients with ER-positive ...
Author and survivor Parul Somani shares how patients with breast cancer can find peace of mind when clinical certainty is ...
A new study shows Signatera ctDNA testing may identify older patients with ER+/HER2- breast cancer who can manage their care ...
For people diagnosed with actual early stage breast cancer, there would be an end date to their drug therapy too. Maybe a year of Herceptin (trastuzumab), maybe five years of anti-estrogen, something, ...
In this segment, Ms. Haupert shares the key questions and concerns she had when discussing treatment options for advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results